Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Inventory (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Change in Inventory for 16 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory fell 5.7% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$374000.0, a 106.37% decrease, with the full-year FY2024 number at $2.5 million, up 32.24% from a year prior.
  • Change in Inventory was $1.4 million for Q3 2025 at Xtant Medical Holdings, up from $814000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.2 million in Q1 2024 to a low of -$3.2 million in Q4 2024.
  • A 5-year average of $299842.1 and a median of $383000.0 in 2021 define the central range for Change in Inventory.
  • Biggest YoY gain for Change in Inventory was 2485.94% in 2024; the steepest drop was 1557.6% in 2024.
  • Xtant Medical Holdings' Change in Inventory stood at -$1.5 million in 2021, then soared by 135.83% to $536000.0 in 2022, then plummeted by 59.51% to $217000.0 in 2023, then plummeted by 1557.6% to -$3.2 million in 2024, then soared by 145.53% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Change in Inventory are $1.4 million (Q3 2025), $814000.0 (Q2 2025), and $535000.0 (Q1 2025).